Pinatuzumab

Tax included
Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL).
MedChemExpress 
HY-P99230

Data sheet

Size
Multiple sizes
Reactivity
Integrin; CD22
Application
Cancer-programmed cell death
CAS
1639820-81-7